A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

NCT01277211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

983

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: ENG 120 µg + EE 15 µg intravaginal ring
DRUG: DRSP 3 mg + EE 30 µg

Sponsor

Organon and Co